17th EBF Open Symposium
November 20-22, 2024
Barcelona, Spain
Booth #8
Booth #8
Come see us at BOOTH #3C
BioAgilytix Presentations at EBF
.jpeg?width=2000&height=1999&name=Lara%20Duchstein_edit%20(1).jpeg "Lara Duchstein_edit (1)")
Applying Context of Use to the Development and Validation of a RT-qPCR Assay for Detecting Gene Knock-Down
Lara Duchstein, Scientific Operations
Wednesday, November 20, 11:40 – 12:00 PM
.jpeg?width=2000&height=2000&name=Marco%20Klinge_edit%20(1).jpeg "Marco Klinge at BioAgilytix")
Evaluating the Utility of the Multi-Tiered Immunogenicity Testing Paradigm
Marco Klinge, PhD, Scientific Operations
Thursday, November 21, 9:40 – 10:00 AM
.jpeg?width=2000&height=2000&name=Matthias%20Reichel_edit%20(1).jpeg "Matthias Reichel at BioAgilytix")
Fit-for-Purpose Non-Clinical Immunogenicity Assessment to Support PK Data Interpretation – A Case Study
Matthias Reichel, Scientific Operations
Friday, November 22, 10:50 - 11:10 AM
BioAgilytix Posters at EBF
.jpeg?width=2000&height=2000&name=Klara%20Szydlo_edit%20(1).jpeg "Klara Szydlo at BioAgilytix")
Application of the MSD S-PLEX Platform for Measuring PK of Low Amounts of an LNP-RNA Translational Bispecific Antibody
Klara Szydlo, PhD, Scientific Operations
.jpeg?width=2000&height=2000&name=Janett%20Schwarz_edit%20(1).jpeg "Janett Schwarz at BioAgilytix")
Application of the Gyrolab® Generic PK Assay Kit to Evaluate Different Human IgG Antibodies in Mouse Studies
Janett Schwarz, PhD, Scientific Operations
BioAgilytix Presentations at EBF
.jpeg?width=400&height=400&name=Lara%20Duchstein_edit%20(1).jpeg "Lara Duchstein at BioAgilytix")
Applying Context of Use to the Development and Validation of a RT-qPCR Assay for Detecting Gene Knock-Down
Lara Duchstein, Scientific Operations
Wednesday, November 20, 11:40 – 12:00 PM
.jpeg?width=400&height=400&name=Marco%20Klinge_edit%20(1).jpeg "Marco Klinge at BioAgilytix")
Evaluating the Utility of the Multi-Tiered Immunogenicity Testing Paradigm
Marco Klinge, PhD, Scientific Operations
Thursday, November 21, 9:40 – 10:00 AM
.jpeg?width=400&height=400&name=Matthias%20Reichel_edit%20(1).jpeg "Matthias Reichel at BioAgilytix")
Fit-for-Purpose Non-Clinical Immunogenicity Assessment to Support PK Data Interpretation – A Case Study
Matthias Reichel, Scientific Operations
Friday, November 22, 10:50 - 11:10 AM
BioAgilytix Posters at EBF
.jpeg?width=400&height=400&name=Klara%20Szydlo_edit%20(1).jpeg "Klara Szydlo at BioAgilytix")
Application of the MSD S-PLEX Platform for Measuring PK of Low Amounts of an LNP-RNA Translational Bispecific Antibody
Klara Szydlo, PhD, Scientific Operations
.jpeg?width=400&height=400&name=Janett%20Schwarz_edit%20(1).jpeg "Janett Schwarz at BioAgilytix")
Application of the Gyrolab® Generic PK Assay Kit to Evaluate Different Human IgG Antibodies in Mouse Studies
Janett Schwarz, PhD, Scientific Operations
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
About the event
EBF was founded in 2006 as an initiative of 12 pharmaceutical companies. The goal was to create a platform for discussions around science, day-to-day procedures, business tools, technologies and, last but not least, regulatory issues. Until 2010, EBF membership was limited to pharmaceutical research and development companies with bioanalytical activities in Europe. From 2011 onwards, the EBF also welcomed CROs involved in bioanalytical activities in Europe. Since 2010, the EBF has been a non-profit organization (vzw) established pursuant to the Belgian Act of 27 June 1921 on non-profit associations, international non-profit associations and foundations. Currently, the EBF counts 78 member companies (April 2024).
Customized approaches to support your bioanalytical needs
BioAgilytix is the trusted partner for global bioanalytical services throughout every phase of the drug development process. We provide custom, fit-for-purpose, and comprehensive bioanalytical support for your program needs. We offer the complete package of pharmacokinetic (PK), immunogenicity, biomarker, and CMC bioanalytical testing in a GxP environment. Our lab services include immunoassay, cell-based assay, molecular biology, and LC/MS assay development, validation, and sample testing, eliminating the need for multiple providers, ensuring efficient data delivery for your therapeutic study.
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
© Copyright 2024 BioAgilytix Labs. All rights reserved.
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
© Copyright 2024 BioAgilytix Labs. All rights reserved.